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Chronic periodontitis (CP) is a common oral disease that confers substantial systemic inflammatory and
microbial burden and is a major cause of tooth loss. Here, we present the results of a genome-wide association
study of CP that was carried out in a cohort of 4504 European Americans (EA) participating in the
Atherosclerosis Risk in Communities (ARIC) Study (mean age—62 years, moderate CP—43% and severe
CP—17%). We detected no genome-wide significant association signals for CP; however, we found suggestive
evidence of association (P < 5 3 1026) for six loci, including NIN, NPY, WNT5A for severe CP and NCR2, EMR1,
10p15 for moderate CP. Three of these loci had concordant effect size and direction in an independent sample
of 656 adult EA participants of the Health, Aging, and Body Composition (Health ABC) Study. Meta-analysis
pooled estimates were severe CP (n 5 958 versus health: n 5 1909)—NPY, rs2521634 [G]: odds ratio [OR 5
1.49 (95% confidence interval (CI 5 1.28–1.73, P 5 3.5 3 1027))]; moderate CP (n 5 2293)—NCR2, rs7762544
[G]: OR 5 1.40 (95% CI 5 1.24–1.59, P 5 7.5 3 1028), EMR1, rs3826782 [A]: OR 5 2.01 (95% CI 5 1.52–2.65,
P 5 8.2 3 1027). Canonical pathway analysis indicated significant enrichment of nervous system signaling,
cellular immune response and cytokine signaling pathways. A significant interaction of NUAK1 (rs11112872,
interaction P 5 2.9 3 1029) with smoking in ARIC was not replicated in Health ABC, although estimates of her-
itable variance in severe CP explained by all single nucleotide polymorphisms increased from 18 to 52% with
the inclusion of a genome-wide interaction term with smoking. These genome-wide association results provide
information on multiple candidate regions and pathways for interrogation in future genetic studies of CP.
INTRODUCTION
Chronic periodontitis (CP) is a common complex disease of
the oral cavity that is characterized by an inflammatory
response to commensal and pathogenic oral bacteria (1) and
is found in about 20% of the adult US population. It manifests
with gingival pocket formation and clinical attachment loss
(CAL) and results in gradual destruction of periodontal
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tissues and tooth-supporting alveolar bone. CP is considered
the main cause of tooth loss among adults and is associated
with severe quality of life impacts (2). Moreover, a growing
body of evidence links the disease with increased risk of sys-
temic conditions, including coronary heart disease (CHD) (3),
pregnancy outcomes (4), poor diabetes mellitus (DM) control
(5) and others. Although definitive mechanistic evidence is
lacking, it has been suggested that these links may be mediated
to some degree via both the microbial component and the
inflammatory burden that characterize the disease (6–8).
Risk factors for CP have been well studied and include
smoking and DM. In addition, age, race and obesity have also
been shown to be important risk indicators (9). A genetic com-
ponent of CP risk was supported by early reports of familial ag-
gregation of severe forms of the disease (10), as well as twin
studies (11), but the magnitude of risk conferred by genetics
and the role of specific genes has been under debate. Recent can-
didate gene studies for CP have focused on genes related to host
immunity and inflammatory response such as cytokines, cell-
surface receptors, chemokines, enzymes and antigen recogni-
tion. Most of these studies have examined polymorphisms in
the interleukin (IL)-1, IL-6, Fc gamma receptor (FCGR2A),
tumor necrosis factor (TNF) alpha, human vitamin D receptor
(VDR), cluster of differentiation (CD)-14, matrix metallo-
proteinase-1, toll-like receptor (TLR), cyclo-oxygenase-2
(COX-2) and C-reactive protein genes with mixed results
(12,13). A recent meta-analysis of studies investigating the
association between CP and IL1 polymorphisms reported sig-
nificantly elevated summary estimates for two IL1A polymorph-
isms [rs1800587 and rs17561, in tight linkage disequilibrium
(LD)—r2 ¼ 1.0; odds ratios (OR ¼ 1.48; 95% confidence
interval (CI ¼ 1.17–1.86))] and one IL1B polymorphism
(rs1143634; OR ¼ 1.54; 95% CI ¼ 1.03–2.30); the authors,
however, noted an underlying heterogeneity in the published
estimates (14). Whereas most of what is known or hypothesized
with regard to genetic risk loci for CP has been based on candi-
date gene studies, to date no genome-wide association study
(GWAS) has been performed. To add to the knowledge base
of the genetic etiology of CP, this study aimed to investigate
genetic risk loci for CP using a genome-wide association
(GWA) approach in the context of a well-defined cohort.
RESULTS
GWA analysis results in the Atherosclerosis Risk
in Communities (ARIC) cohort
The Atherosclerosis Risk in Communities (ARIC) participants
had a mean age of 62 years, with a balanced sex distribution.
Twelve percent were current smokers, and 11% had DM.
In terms of Centers of Disease Control [CDC/American
Academy of Periodontology (AAP)] periodontal diagnoses,
17% (n ¼ 761) were classified as severe, 43% (n ¼ 1920) as
moderate and 40% (n ¼ 1823) as healthy. The descriptive char-
acteristics of the European American Dental ARIC cohort par-
ticipants that were included in this analysis are presented in the
Supplementary Material, Table S1. After exclusions that are
described in the Materials and Methods section, there were 2
135 236 single nucleotide polymorphisms (SNPs) included in
the GWA analysis. Genomic inflation factors were low, 1.019
for moderate and 1.024 for severe CP (Fig. 1). No genome-wide
significant signals were noted; however, 26 SNPs in 6 loci (3 for
moderate and 3 for severe CP) emerged below a P , 5 × 1026
threshold (Fig. 2). The SNP with the lowest P-value in each of
these six loci was, thus, prioritized for further annotation and
follow-up (Table 1). The quality scores and proxies of these
prioritized SNPs are presented in the Supplementary Material,
Table S2. Adjustment for smoking and diabetes did not result
in any important change in estimate (less than 10%) of associ-
ation for these SNPs (Supplementary Material, Table S3). Simi-
larly, sex-stratified analyses did not reveal any departures from
homogeneity (Supplementary Material, Table S4). Consistent
with the current trends in reporting of GWAS (15), we have
made available the results of the entire set of SNPs that we
investigated in ascending P-value order at: http://genomewide.
net/public/aric/dental/periodontitis/CDC/cdc1vs0_full.txt and
Figure 1. Quantile–quantile plots of genome-wide association analysis results
of severe CP (A) and moderate CP (B) complex in the ARIC cohort.
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Visualizations of the six loci of interest, along with nearby
genes and recombination rates, are presented in Figure 3. For
severe CP, the strongest (with respect to P-value) association
in the 14q21 locus was produced by rs12883458. This SNP is
located in an intron of Ninein (GSK3B interacting protein;
NIN). The minor allele [C] showed a 3.5% enrichment among
severe CP patients and was associated with an OR ¼ 1.89
(95% CI ¼ 1.48–2.41; P ¼ 3.5 × 1027). In the 7p15 locus,
the major allele [G] of an intergenic SNP, rs2521634 [minor
allele frequency (MAF) [A] ¼ 0.25; 47 Kb downstream from
Neuropeptide Y (NPY)], produced an OR ¼ 1.47 (95% CI ¼
1.25–1.73; P ¼ 1.6 × 1026). Similarly, the major allele [G]
of rs11925054 (MAF [T] ¼ 0.14) in the 3p21 locus, down-
stream from wingless-type mouse mammary tumor virus inte-
gration site family, member 5A (WNT5A) and ELKS/
RAB6-interacting/CAST family member 2 (ERC2), produced
the strongest signal in the region (OR ¼ 1.69; 95% CI ¼
1.37–2.10; P ¼ 6.5 × 1027), showing 4% enrichment among
severe CP patients.
With regard to moderate CP, the SNP with the lowest
P-value in the 6p21.1 locus was rs7762544 (MAF [G] ¼
0.18; OR ¼ 1.41; 95% CI ¼ 1.24–1.60; P ¼ 1.1 × 1027).
This variant is 61 Kb downstream from natural cytotoxicity
triggering receptor 2 (NCR2), and its minor (risk) allele
Figure 2. Manhattan plots of genome-wide association analysis results of severe CP (A) and moderate CP (B) complex in the ARIC cohort.
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showed 4.4% enrichment among moderate CP patients when
compared with healthy participants. SNP rs3826782 (MAF
[A] ¼ 0.07), located in an intronic region of Egf-like module
containing, mucin-like, hormone receptor-like 1(EMR1)
and 30 Kb downstream from Vav 1 guanine nucleotide
exchange factor (VAV1), provided the strongest signal in that
locus (OR ¼ 2.00; 95% CI ¼ 1.48–2.70; P ¼ 4.0 × 1026),
showing a small 1% enrichment among ARIC ‘cases’. Exam-
ination of the SCAN database for expression-associated data
(Supplementary Material, Table S5) revealed that this SNP
has been associated (P ¼ 2 × 1025) with the expression of
GPR113 on lymphoblastoid cell lines (LCLs). GPR113 has
been found to be expressed intraorally, by taste receptor
cells (16), and has functions on the neuropeptide signaling
pathway [Gene Ontology (GO) accession: 0007218] and
signal transducer activity (GO accession: 0004871)—path-
ways relevant to NPY. Finally, the major allele [G] of
rs12260727 (MAF [A] ¼ 0.15) in the 10p15 locus was asso-
ciated with OR ¼ 1.54 (95% CI ¼ 1.30–1.82; P ¼ 6.0 ×
1027). SNP rs12260727 is located distant (700 Kb upstream)
from the closest gene CUGBP, Elav-like family member 2
(CELF2). As expected, all SNPs in LD (r2 . 0.80) displayed
directionally consistent and of a similar magnitude effect
estimates as the index SNP at each locus.
Examination of the prioritized SNPs in the subset of 1020
European American Dental ARIC participants previously
reported in a GWAS of periodontal pathogen colonization
by Divaris et al. (17) showed no important association with
high colonization with periodontal pathogens of the ‘red’ or
‘orange’ complex, or individual bacteria such as Aggregati-
bacter actinomycetemcomitans and Porphyromonas gingivalis
(Supplementary Material, Table S6). The number of concord-
ant effect estimates (n ¼ 13) that we detected in this additional
‘look-up’ was not statistically different from what would be
expected by chance alone, among 24 examined effect esti-
mates (binomial test P ¼ 0.5). However, NPY and NCR2
were two loci that showed concordant effect estimates with
all four bacterial traits. Examination of additional polymorph-
isms in the CD14, FCGR2A, IL1A, IL1B, IL1RN, IL4, IL6,
IL10, TLR4, TNF and VDR genes that have previously been
reported (13) as associated with CP in at least one candidate
gene study among whites of European descent did not show
any evidence of association (Table 2).
Replication and meta-analysis in the Health, Aging
and Body Composition (Health ABC) Study
Three SNPs associated with severe CP (rs12883458,
rs2521634 and rs11925054) and three SNPs associated
with moderate CP (rs7762544, rs3826782, rs12260727) in
the ARIC Study (P , 5 × 1026) were investigated using the
next largest cohort available to us, the Heath ABC Study
(n ¼ 686). The descriptive characteristics of the Health,
Aging, and Body Composition (Health ABC) Study partici-
pants included in this analysis are presented in Supplementary
Material, Table S1.
Of the three SNPs investigated with severe CP, one SNP
(NPY locus: rs2521634) was nominally associated with
severe CP in the Health ABC Study (OR ¼ 1.64; 95% CI ¼
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Figure 3. Visualization of the six loci that were prioritized based on a P , 5 × 1026 criterion in the ARIC cohort. Three loci were prioritized based on their
association with severe CP (A: 14q21, NIN, rs12883458; B: 7p15, NPY, rs2521634; C: 3p21, WNT5A/ERC2, rs11925054) and three for their association with
moderate CP (D: 6p21.1, NCR2, rs7762544; E: 19p13.3, EMR1, rs3826782; F: 10p15, rs12260727). The vertical axis corresponds to each locus’ (index)
SNP2log10 P-value; the SNP associated with the lowest P-value is labeled. The overlaid recombination rate plot and the color-coded pairwise linkage disequi-
librium values with index SNPs were calculated based on HapMap II–CEU (human genome 18, build 36).
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and magnitude as in ARIC (Table 3). Similarly, the EMR1
locus (rs3826782) showed concordant effect direction and
magnitude (OR ¼ 2.06; 95% CI ¼ 1.03–4.60; P ¼ 0.06).
The NCR2 (rs7762544) locus showed similar effect direction
for moderate CP risk in Health ABC (OR ¼ 1.32, 95% CI ¼
0.81–2.14; P ¼ 0.27). None of these SNPs met statistical sig-
nificance criteria based on a Bonferroni-corrected (assuming
a ¼ 0.05 and six independent tests) P-value criterion of
0.0083. No significant effect was observed with rs12260727
at the 10p15 locus (OR ¼ 0.93; 95% CI ¼ 0.56–1.57; P ¼
0.8). The remaining three loci showed non-significant effects
of opposite direction in Health ABC. Allele frequencies of
these SNPs in the Health ABC sample are presented in the
Supplementary Material, Table S7.
The three SNPs (rs2521634, rs7762544 and rs3826782)
that showed concordant effect direction and magnitude in
the discovery and replication cohorts were carried forward for
meta-analysis, resulting in the following summary estimates:
severe CP—NPY, rs2521634 [G]: ORpooled ¼ 1.49 (95% CI ¼
1.28–1.73; P ¼ 3.5 × 1027); moderate CP—NCR2,
rs7762544 [G]: ORpooled ¼ 1.40 (95% CI ¼ 1.24–1.59; P ¼
7.5 × 1028), EMR1, rs3826782 [A]: ORpooled ¼ 2.01 (95%
CI ¼ 1.52–2.65; P ¼ 8.2 × 1027).
Genome-wide interactions with smoking
The exploratory genome-wide interaction analysis between all
SNPs and smoking history (ever versus never smoker)
revealed one genome-wide significant locus for moderate CP
at NUAK1 (12q23.3), where the intronic rs11112872 (MAF
[G] ¼ 0.42) produced an interaction term P ¼ 2.9 × 1029.
Smoking-stratified estimates of moderate CP for the minor
allele were never smokers (n ¼ 1825)—OR ¼ 0.77 (95%
CI ¼ 0.67–0.88; P ¼ 2.2 × 1024) and ever smokers (n ¼
1838)—OR ¼ 1.42 (95% CI ¼ 1.23–1.64; P ¼ 2.8 × 1026).
This interaction for moderate CP was not replicated in
Health ABC (never smokers—n ¼ 227, ever smokers—n ¼
232 in the moderate CP versus health analysis), where the
stratified estimates were of discordant direction when com-
pared with ARIC. All other interaction estimates for moderate
and severe CP were of substantially smaller magnitude
(P-values around 1026 or greater) and are available as




Estimation of variance explained by all SNPs
The results of the examination of heritable variance explained
by all GWAS SNPs are presented in Table 4. Variance
explained (h2) estimates were consistently higher for severe
CP when compared with moderate CP. Some variations in
the h2 estimates were also noted with regard to the SNP sets
that were used for analyses. Interestingly, higher variance in
moderate disease was explained with the use of imputed
versus genotyped SNPs, whereas the inverse was true for
severe CP. After adjustment for population stratification and
using imputed SNPs, h2 was 7% for moderate CP and 8%
for severe CP. Higher phenotypic variance (18%) was
explained in severe disease with the use of genotyped-only
SNPs. However, standard errors were large for all these esti-
mates. Notably, the inclusion of a G × E interaction term
with smoking history produced high estimates of variance
jointly explained by SNPs and their interaction with
smoking, ranging between 36 and 41% for moderate CP and
42 and 52% for severe CP.
Canonical signaling pathway analysis
Of the 147 Ingenuity Pathway Analysis (IPA) canonical sig-
naling pathways that were tested in the moderate and severe
CP results data, 11 were significantly enriched (P , 3.4 ×
1024) (Supplementary Material, Figs S1 and S2). Contrarily,
none of the metabolic pathways that we tested as controls
was associated with the data. Two of the identified pathways
(axonal guidance and neuropathic pain signaling) were
common for severe and moderate CP, eight (i.e. synaptic long-
term potentiation, cAMP responsive element binding protein
signaling in neurons, N-formyl-methionyl-leucyl-phenylalan-
ine (fMLP) signaling in neutrophils, neuronal nitric oxide syn-
thase 1 signaling in neurons and virus entry via endocytic
pathways) were unique to severe CP and one (amyotrophic
lateral sclerosis signaling) was unique to moderate CP.
Overall, neurotransmitters and nervous signaling pathways
were the majority (9 out of 12) of those enriched. Axonal guid-
ance signaling was the most significant (severe CP—P ¼
2.1 × 1027, ratio ¼ 0.194; moderate CP—P ¼ 1.4 × 1025,
ratio ¼ 0.173) and included WNT5A, the only prioritized
locus that was represented in the top pathways. Axonal
Table 2. P-values for the association with severe and moderate CP in the Den-
tal ARIC GWAS of polymorphisms that have been examined and reported as
associated in at least one study among whites of European descent in the review











CD14 rs2569190 139993100 [A] 0.47 0.57 0.75
FCGR2A rs1801274 159746369 [A] 0.50 0.66 0.37
IL10 rs1800872 205013030 [T] 0.22 0.89 0.56
IL1A rs1800587 113259431 [A] 0.31 0.20 0.51
rs17561 113253694 [A] 0.31 0.20 0.50
IL1B rs1143634 113306861 [A] 0.26 0.21 0.27
IL1RN rs419598 113603678 [C] 0.27 0.31 0.97
IL4 rs2070874 132037609 [T] 0.15 0.17 0.62
rs2243250 132037053 [T] 0.15 0.17 0.63
IL6 rs1800795 22733170 [C] 0.43 0.87 0.18
rs2069827 22731981 [T] 0.10 0.31 0.49
MMP1 rs475007 102174522 [T] 0.44 0.90 0.12
TLR4 rs4986791 119515423 [T] 0.06 0.93 0.27
rs4986790 119515123 [G] 0.06 0.93 0.27
TNF rs1800629 31651010 [A] 0.17 0.68 0.77
VDR rs731236 46525024 [G] 0.41 0.69 0.59
rs1544410 46526102 [T] 0.41 0.68 0.59
aMinor allele frequency.
bBased on logistic regression, log-additive models, including terms for age, sex,
study center and ancestry (10 first PCs).
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guidance signaling remained the top canonical pathway for
both moderate and severe CP when the pathway analysis
was repeated using a smaller set of loci that met more stringent
association criteria (P , 1023), but did not reach statistical
significance. The remaining three identified pathways were
cellular immune response related, namely fMLP signaling in
neutrophils, CXCR4 signaling and virus entry via endocytic
pathways.
DISCUSSION
In this work, we present the results of the first genome-wide
investigation of CP. In our GWAS, we identified six loci pro-
viding suggestive evidence of association with CP. Although
no signals met genome-wide significance criteria, we found
that three of these loci (NPY, NCR2 and EMR1) had concord-
ant effect direction in a replication sample, with NPY being
nominally associated with severe CP. Similarly, a genome-
wide significant interaction of NUAK1 with smoking was not
replicated. Nevertheless, our estimates of phenotypic heritabil-
ity explained by all SNPs were significantly increased with
the inclusion of a G × E interaction term with smoking. Fur-
thermore, our findings suggest an important role of neurotrans-
mitter and nervous system signaling pathways in the risk of
CP, complementary to immune response-related ones.
Although limited by its sample size of about 5000 subjects,
this study was conducted using a well-defined cohort with
detailed characterization of CP, using full-mouth periodontal
examinations and the latest consensus taxonomy of CP.
These results provide a wealth of new information on potential
candidate genes that will require further exploration, replica-
tion and validation in future studies. Our GWA scan did not
identify any SNP that met strict genome-wide statistical sig-
nificance criteria (P , 5 × 1028). However, many true
signals, elements of the ‘missing heritability’ may be found
below this threshold (18–22). Therefore, we used a more
lenient P-value threshold for prioritization and annotation of
a set of ‘promising’ SNPs, reported estimates of variance
explained by all GWAS SNPs and made available the com-
plete set of our GWAS results.
The fact that virtually all prioritized loci are related to host
immunity is consistent with the current understanding of the
etiology and pathogenesis of periodontal diseases (1,8,23).
The preponderance of neurotransmitter and nervous system
signaling pathways among those significantly associated with
our data echo reports that emphasize the role of the nervous
system in the pathophysiology of peripheral inflammation
and suggest a neurogenic inflammatory component for peri-
odontitis (24). In fact, a recent study found differences in gin-
gival crevicular fluid levels of NPY between healthy and
periodontitis-affected sites (25). Nevertheless, CP is a
complex, polygenic disease, wherein multiple genes are
likely to confer risk or protection by influencing the host in-
flammatory response and the qualitative and quantitative com-
position of the oral microbiome. Noteworthy, two of the six
prioritized loci (NPY and NCR2) showed concordant effect
estimates for all examined ‘high periodontal pathogen colon-
ization’ traits in a previous GWAS (17), an observation that
parallels the pathogenic oral microbial shift that is characteris-
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It is well established that ‘environmental’ and behavioral
factors are important in CP, with the major lifestyle risk
factor being smoking (26,27). Although smoking is an unlike-
ly confounder of genetic effects on CP risk, synergistic effects
are likely. Tomar and Asma (28) used 1988–1994 NHANES
data to estimate that up to 52% of periodontitis cases in the
USA were attributable to current or former smoking,
whereas among current smokers, 75% of periodontitis cases
were attributable to smoking. Although our study was under-
powered to efficiently examine G × E interactions, we
detected one significant interaction of NUAK1 with smoking
that was not replicated in the Health ABC sample. Although
some level of misclassification in the environmental exposure
cannot be ruled out, we support that further investigation of
candidate gene interactions with smoking, possibly involving
more sensitive measures such as serum cotinine levels and
smoking pack years, may lead to the discovery of novel risk
loci for CP. The overall strong effect of smoking was con-
firmed in our data, where the inclusion of a smoking inter-
action term with the genetic heritable variance component
improved significantly the phenotypic variance explained in
both periodontitis traits, reaching up to 52% for severe peri-
odontitis. Although these results were imprecise and should
be interpreted with caution, they provide support for a
strong interaction of smoking with common variation that
should be explored in detail in future genetic and
mechanistic studies.
The lack of an overlap of risk loci for the moderate and
severe disease traits is not surprising. Although these results
are preliminary, the lack of overlap is consistent with our
approach of examining the two CP diagnoses separately: mod-
erate and severe CP are considered largely distinct entities,
rather than disease progression stages. Since the first
population-based studies of periodontal disease natural
history, the most severe forms of disease were distinguished
into moderate and mild forms; those in the top 15–18% of
the distribution have different rates of clinical progression, mi-
crobial composition, host response and molecular (inflamma-
tory) characteristics (29–31). Interestingly, the heritability
estimates that we obtained for the severe CP trait in this
GWAS were consistently higher when compared with those
obtained for the moderate trait. Also, from a statistical stand-
point, the lack of overlap is not surprising because small sto-
chastic variations can have a big impact on the tails of the test
statistic distribution. However, because these traits share a
common pathogenetic underpinning, and in our analyses we
used the same controls for both contrasts, some overlap in
GWA signals should be anticipated. The discovery of the
same nervous system signaling pathway as the most signifi-
cantly associated with both traits may indeed be an indication
of a shared pathogenetic framework. Explorations at lower
P-value thresholds may reveal more ‘good signals’ and
common risk loci.
The heritability estimates attributable to common variation
that we obtained are lower when compared with previous esti-
mates reported by Michalowicz et al. (11,32) from studies
among twins. A more recent study used an animal model to
estimate 35% heritability in alveolar bone loss, after adjust-
ment for age and sex (33). As noted by Yang et al. (34),
heritability estimates obtained via the use of GWAS SNPs
Table 4. Phenotypic variance explained for moderate and severe CP by all genotyped and imputed autosomal SNPs available and their interaction with smoking
history (ever/never smoker) using REML analysis implemented with GCTA [Yang et al. (56)], among the European American participants of the Dental ARIC
study (n ¼ 4504)
Genotyped SNPs Imputeda SNPs
Exclusion filters: MAF , 0.05 MAF , 0.05, R2b , 0.6 MAF , 0.05, R2b , 0.3
n (SNPs)c: 656 292 2 104 905 2 131 070
Varianced explained (SE) Varianced explained (SE) Varianced explained (SE)
Moderate CP
Only SNPs considered 0.057 (0.13) 0.097 (0.11) 0.099 (0.11)
+10 PCs for population structure 0.006 (0.14) 0.068 (0.12) 0.069 (0.12)
+10 PCs, sex 0.000 (0.14) 0.048 (0.12) 0.049 (0.12)
+10 PCs, age 0.008 (0.14) 0.082 (0.12) 0.083 (0.12)
+10 PCs, sex, age 0.000 (0.14) 0.066 (0.12) 0.067 (0.12)
+10 PCs, sex, age, [G] × [smoking history]e 0.358 (0.26) 0.405 (0.23) 0.391 (0.24)
[G] × [E] term (LRT X2) P 0.1 0.04 0.04
Severe CP
Only SNPs considered 0.298 (0.18) 0.214 (0.15) 0.212 (0.15)
+10 PCs for population structure 0.175 (0.19) 0.083 (0.16) 0.080 (0.16)
+10 PCs, sex 0.221 (0.19) 0.110 (0.16) 0.109 (0.16)
+10 PCs, age 0.171 (0.19) 0.097 (0.16) 0.094 (0.16)
+ 10 PCs, sex, age 0.220 (0.19) 0.127 (0.16) 0.127 (0.16)
+10 PCs, sex, age, [G] × [smoking history]e 0.515 (0.35) 0.425 (0.31) 0.418 (0.31)
[G] × [E] term (LRT X2) P 0.04 0.06 0.06
GCTA, genome-wide complex trait analysis; MAF, minor allele frequency; SE, standard error; PCs, principal components; LRT, likelihood ratio test comparing
models, including the [G] × [E] term against ‘reduced’ models without the interaction term.
aImputed using HapMap II-CEU.
bImputation quality score.
cNumber of SNPs that were used to estimate the GRM after exclusions, among the study participants as a first step in the GCTA prior to conducting REML.
dAdjusted to the prevalence of CP in the Dental ARIC cohort, moderate CP—0.43 and severe CP—0.17.
eSmoking history was defined as a binary variable, where 0: never smoker (47% of participants) and 1: ever smoker (53% of participants).
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are likely underestimates of the true heritability due to
common variation because of incomplete LD between causal
variants and available SNPs and the fact that causal variants
may have lower MAF when compared with all other SNPs
examined. We anticipate that the precision and validity of
these estimates will improve as higher density imputations
and whole genome sequencing are becoming more common
and larger GWAS samples more feasible.
A recent GWAS of generalized aggressive periodontitis
(gAgP) among a sample of whites of European descent iden-
tified associations with a susceptibility locus on 9p34.3 intron-
ic to the glycosyltransferase 6 domain containing 1 (GLT6D1)
gene and a shared susceptibility locus on 9p21.3 for both gAgP
and CHD (35,36). However, gAgP is a rare form of periodon-
titis, found in less than 1% of adults and is a distinct entity
from CP. Noteworthy, none of the previously reported CP
risk candidate gene polymorphisms met nominal statistical
significance criteria in our study. This finding requires
further study, nevertheless it may be reflective of the unavoid-
able systematic biases that may affect small sample size case-
control candidate gene studies; in this respect, the ‘agnostic’
genome-wide approach that we employed using two
population-based samples constitutes an improvement.
Our examination of two dichotomous disease traits, includ-
ing shared ‘healthy’ controls in both cohorts can be considered
as one of the study limitations. Examinations of quantitative
traits such as extent of attachment loss, probing depth and/or
tooth loss that capture a continuum in disease severity might
offer a more powerful approach when conducting GWAS;
however, we suggest that using current diagnostic criteria
for CP is a valuable first step in exploring the genetic basis
of the disease. We are aware of the ongoing debate on CP
definition and classification (37,38). Although the CDC/AAP
classification is the consensus taxonomy implemented in epi-
demiologic studies and surveillance, it has several limitations.
First, the case definitions include a reversible clinical marker
(probing depth) and second, disease ascertainment is influ-
enced by tooth loss (sites with severe disease are lost and
unobservable). Although the latter issue is common to all
CP classifications, improvements have been suggested. For
example, Offenbacher et al. (31) introduced a refined CP clas-
sification characterizing the disease’s biological (versus
clinical-only) phenotype, a feature that may be advantageous
in the exploration of genetic effects. Future research directions
may include the interrogation of CP ‘endophenotypes’ (39),
pleiotropic effects (40) in the context of phenome-wide asso-
ciation studies (41) and composite phenotypes involving
clinical, molecular and oral microbiome characteristics. Such
investigations may help shed light on the complex CP
etiology, pathogenesis and variable clinical manifestation, as
well as clarify possible shared genetic underpinnings with
other systemic conditions.
In summary, we present the results of the first GWAS of CP
among EA. Although none of the reported loci reached
genome-wide significance levels, our data provide support
for further investigation for the role of several loci in the
risk of CP. Acknowledging that interpretation of these
results should be made with caution, we support that the sug-
gestive evidence on the six prioritized loci, the heritability
estimates, including the significant interaction with smoking,
the associated canonical signaling pathways involving the
nervous system and immunity and the full set of GWAS
results, may serve as a rich hypothesis-generating resource.
Future research, including larger GWA, replication and fine-
mapping studies, as well as mechanistic and experimental
investigations will be required to further our understanding
of the pathogenesis of the disease and may lead to novel pre-
ventive and therapeutic approaches.
MATERIALS AND METHODS
Study population
Our discovery GWA analysis was performed in a sample of
European American participants of the ARIC study (42) age
53–74. The ARIC is a prospective cohort study of atheroscler-
osis, cardiovascular disease risk factors and outcomes that
enrolled 15 792 community-dwelling residents in 4 US com-
munities (Jackson, MS; Washington County, MD; suburban
Minneapolis, MN; and Forsyth County, NC) between 1987
and 1989. The Dental ARIC is a National Institute of Dental
and Craniofacial Research-funded ancillary study that took
place during the fourth ARIC visit (1996–1998) and included
complete oral-dental examinations in a subset (n ¼ 6017) of
dentate ARIC participants. The Health ABC Study is a
National Institute on Aging-sponsored longitudinal investiga-
tion examining factors that contribute to incident disability
and functional decline of healthier older persons, with a par-
ticular emphasis on changes in body composition in old age
(43). Between April 1997 and June 1998, the Health ABC
study had recruited 3075 70–79-year-old well-functioning
community-dwelling adults. Study participants were recruited
from a random sample of Medicare beneficiaries in Pittsburgh,
Pennsylvania and Memphis, Tennessee. As part of the study
year 2 and 3 follow-up clinical visits (1998–2000), a total
of 1133 EA and African American participants received
complete dental and periodontal examinations (44,45).
Phenotype measurement and definition
As part of the Dental ARIC, ancillary study participants under-
went detailed oral-periodontal examinations that recorded the
number of missing teeth, probing depths, attachment loss mea-
surements and bleeding upon probing at six sites per tooth,
including third molars. Dental ARIC clinical examiners were
trained and calibrated against a standard examiner, with
kappas indicating excellent to outstanding level of agreement
(46). During the Health ABC oral examinations, trained and
calibrated examiners obtained clinical plaque index, gingival
index, PD and CAL measurements. An a priori minimum
level of 90% agreement on all measures was set as a bench-
mark and was achieved by all examiners (45). We used the
CDC and AAP consensus three-level classification for the
disease trait definition in both cohorts. The CDC/AAP tax-
onomy uses CAL and PD criteria to define three CP categories
as, healthy-mild (n ¼ 1864), moderate (n ¼ 1961) and severe
(n ¼ 785) (47). Based on this definition, we created two
dichotomous traits: severe CP (severe versus healthy) and
moderate CP (moderate versus healthy). To fully describe
the clinical features of these traits, we present the distribution
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of the following clinical periodontal measures, overall and
stratified by periodontitis diagnosis in each cohort: plaque
score, gingival index, extent of bleeding on probing, mean
probing depth (mm), mean attachment loss (mm), extent of
probing depth (≥4 mm), extent of attachment loss (≥3 mm)
and number of natural teeth.
Genotyping, imputation and quality control
In the ARIC study, population DNA was extracted from blood
samples drawn from an antecubital vein into tubes containing
serum separator gel. Blood samples were analyzed at a central
ARIC laboratory in Houston, TX, USA. Genotyping was per-
formed using the Affymetrix Genome-Wide Human SNP
Array 6.0 chip that offers 906 600 markers for SNPs. The
quality control procedures included initial blind duplicate
genotyping and identification/flagging of SNPs with k ,
0.95 and reconciliation of unintentional duplicate samples
(17 duplicates and 1 triplicate). Imputation to 2.5 million
markers was performed using 669 450 SNPs and the MACH
program version 1.0.16 (48), based on HapMap Phase II
CEU build 36. The SNPs used for imputation were selected
from 839 048 autosomal SNPs restricted to those with
MAF . 0.01 (129 543 excluded), Hardy–Weinberg equilib-
rium (HWE) P . 1025 (12 432 excluded) and call rate
.95% (1693 excluded). We used the following criteria for ex-
clusion of SNPs from further analyses: quality score , 0.8 and
missing data rate . 10% after imputation and MAF of ,5%.
In the Health ABC Study, population genomic DNA was
extracted from buffy coat collected using PUREGENEw
DNA Purification Kit during the baseline examination. Geno-
typing was performed by the Center for Inherited Disease Re-
search using the Illumina Human1M-Duo BeadChip system.
Illumina BeadStudio was used to call genotypes. Samples
were excluded from the dataset for the reasons of sample
failure, sex mismatch and first-degree relative of an included
individual based on genotype data. Genotyping was successful
for 1 151 215 SNPs in 1663 European American participants.
Imputation for autosomal SNPs was done using MACH
version 1.0.16. SNPs with MAF ≥ 1%, call rate ≥ 97% and
HWE P ≥ 1026 were used for imputation using HapMap
Phase II CEU build 36 resulting in a final set of 2 543 887
SNPs.
Population stratification
To obtain estimates of relatedness and population stratification
in ARIC, a subset of 85 947 ‘high quality’ SNPs was selected.
These SNPs met the following criteria: MAF ≥ 0.1, call
rate . 99.5%, HWE P ≥ 1023, autosomal, with annotation
in the platform annotation file, not labeled ‘AFFX’ or
‘chromosome 0’ and not monomorphic. Using these SNPs,
identity-by-state (IBS) allele sharing distance (DST values)
was computed using PLINK (49), as such: DST ¼ IBS dis-
tance (IBS2 + 0.5 × IBS1)/(n SNP pairs). First-degree relative
status was assigned to pairs of individuals with DST ≥ 0.8,
and second-degree relatives were considered those with
0.763 ≤ DST , 0.8. There were 380 pairs of first degree and
207 pairs of second-degree relatives identified among the
ARIC white participants of European descent. To minimize
exclusions, related pairs were broken by iterative selection
of individuals with most relatives using a custom-written
program.
Population stratification was further evaluated with princi-
pal component (PC) analysis using the EIGENSTRAT
program (50). The previously chosen set of SNPs was used
for the computation of 10 PCs. Genetic outliers were consid-
ered those that were farther than 8 standard deviations away
from any of 10 PCs over 10 runs of PC computation. Based
on DST and PC criteria, there were 716 subjects flagged for
removal from the analysis [206 as genetic outliers based on
PCs and 16 based on average DST values (‘too little IBS
sharing’ with the rest of the sample), 351 first-degree relatives
and 143 second-degree relatives. All but 10 second-degree
relatives (whose relatives were excluded as genetic outliers)
were reentered in the dataset and were assigned PCs. After
exclusion of 364 individuals (4%), there were 9349 European
Americans who were included in the GWA analysis, and
of those, 4504 had periodontal phenotype data available as
dental ARIC participants.
Analytical strategy
The association between SNPs and the two disease traits
(severe and moderate CP) was tested using logistic regression
models assuming log-additive allelic effects, adjusting for age,
sex, examination center and ancestry (10 first PCs). Per allele
ORs and 95% CIs and associated P-values were estimated for
each CP trait. Consistent with the current trends in reporting of
GWAS (15), we have made available the results of the entire
set of SNPs that we investigated. Because no confounding of
the association between SNPs and the examined traits is
expected by CP risk factors, the main analysis models were
not adjusted for smoking or diabetic status. However, in the
Supplementary Material, we present the results (effect esti-
mates and percentage of change in estimate) of additional ex-
ploratory analyses, adjusting for smoking status and diabetes.
In the ARIC ‘discovery’ cohort, we applied a multiple-test
correction assuming 1 million independent tests, resulting to
a genome-wide significance level of P , 5 × 1028. All
genetic analyses were performed with the ProbABEL software
(51). An a priori threshold of P , 5 × 1026 was set for priori-
tizing SNPs for further investigation and replication in the
Health ABC Study. To inspect for any substantial differences
in the effects of prioritized SNPs between males and females
in ARIC, we conducted additional exploratory analyses strati-
fied by sex. The departure from between-sexes homogeneity
was assessed by inspection of non-overlapping CIs. To
provide a more comprehensive view of the potential role of
these SNPs in periodontitis-related traits, we obtained and em-
pirically examined their effect size, direction, and P-values for
four additional ‘high periodontal pathogen colonization’ traits
that were available for a subset of participants in the European
American Dental ARIC cohort (n ¼ 1020) and have been
previously studied in the context of a GWAS of the
oral-periodontal microbiome (17).
Post-analysis procedures included the generation of quan-
tile–quantile (Q–Q) and Manhattan plots and detailed annota-
tions of gene context. We also examined the prioritized SNPs
association with gene expression (as expression quantitative
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trait loci) using the SCAN (http://www.scandb.org) database
and reported the P-values associated with gene expression
on LCLs. Furthermore, P-values and effect estimates [OR
(95% CI)] of the prioritized variants (one ‘top’ SNP per prior-
itized locus, as determined by the lowest P-value) in the
Health ABC Study were obtained and examined for nominal
significance, as well as for effect direction and magnitude con-
cordance. ‘Replication’ was determined as concordant effect
direction and nominal significance (P , 0.05) in the Health
ABC Study. Effect estimates of SNPs that did not show
substantial heterogeneity and ‘generalized’ to the Health
ABC Study were combined in inverse-variance weighted
meta-analysis to produce pooled (summary) ORs.
The prioritized SNPs were annotated using WGAViewer
ver.1.26l (52) and Snipper ver. 1.2 (http://csg.sph.umich.edu/
boehnke/snipper/), and regions of interest were viewed using
LocusZoom ver.1.1 (53). We used PolyPhen-2 for the predic-
tion of potentially damaging missense changes (54) and
METAL (55) for the summarization and meta-analysis of esti-
mates derived from the two cohorts. We used additional online
resources of the National Center for Biotechnology Informa-
tion (NCBI http://www.ncbi.nlm.nih.gov/). Reporting of
genes was based on the ‘HUGO Gene Nomenclature’
naming convention (http://www.genenames.org). The full
names and genomic locations of the reported genes are pre-
sented in the Supplementary Material, Table S8.
The estimation of heritable variance (h2) in the two peri-
odontitis traits explained by all available SNPs in the
present GWAS was performed with the use of GCTA (56).
GCTA is based on a two-step method, where in the first
step, all available SNPs are used to estimate a genetic relation-
ship matrix (GRM) among all study participants. Subsequent-
ly, the GRM is used in restricted maximum likelihood
(REML) analyses to estimate the proportion of variance
explained by all SNPs. Adjustment for population stratification
and the inclusion of additional covariates, including gene–en-
vironment interaction (G × E) terms are feasible in the REML
step. Because the variance explained may be influenced by the
unknown LD structure of available SNPs with causal variants,
we examined three different sets of SNPs for the computation
of the GRM: genotyped SNPs with MAF ≥0.05, as well as
combinations of imputed SNPs with MAF ≥ 0.05 and imput-
ation quality score (R2) ≥ 0.3 and ≥0.6. The maximum
number of SNPs used was 2 131 070. Additionally, the inclu-
sion of an interaction term with smoking was examined using
a binary definition of smoking history (ever/never smoker) and
inspecting the variance explained and a likelihood ratio test
P-value (using a P , 0.2 criterion, as the examination of inter-
action effects is based on de facto underpowered analyses).
For the conduct of pathway analyses, we first identified a set
of ‘independent’ signals providing nominal evidence associ-
ation (using an arbitrary P-value criterion of ,1022) for
each of the two disease traits using LD pruning. This step
was implemented with PLINK, filtering SNPs that were corre-
lated (r2 ≥ 0.1) with the index SNP (lowest P-value) in each
locus and within a distance of 400 Kb. Next, the closest or har-
boring gene was assigned to each locus, if one was found
within 100 Kb of the index SNP. Thus, 2 sets of 2328 loci
and genes nominally associated with moderate CP and 2425
nominally associated with severe CP were carried forward to
pathway analysis that was conducted using IPA (Ingenuityw
Systems, www.ingenuity.com, Redwood City, CA, USA). As
a sensitivity analysis, we explored the use of a more stringent
criterion (P , 1023) to carry forward association signals in
pathway analyses that resulted in 2 additional sets of loci, enu-
merating 361 genes for each disease trait.
Consistent with the current understanding of pathogenesis
of periodontitis that entails dysbiotic host–pathogen interac-
tions, detrimental immune response (1,8) and the emerging
role of the nervous system (24,57), we investigated the enrich-
ment of ingenuity canonical signaling pathways in the follow-
ing categories: cellular immune response, cytokine signaling,
humoral immune response, neurotransmitters and other
nervous system signaling and pathogen-influenced signaling.
There were 147 canonical pathways listed in these categories
(http://genomewide.net/public/aric/dental/periodontitis/CDC/
CP_candidate_canonical_pathways.xls). To serve as control,
we examined the enrichment of the IPA metabolic group of
pathways (n ¼ 126). The association between pathways and
the data was determined with Fisher’s exact test and a
Bonferroni-corrected P-value threshold for multiple pathways
tested (critical P , 3.4 × 1024). For each pathway, we also
present the ratio of the number of molecules in the data that
mapped to each canonical pathway over the number of
molecules in the pathway.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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